WINDWARD BIO GROUP AG — Form 4
Filed November 18, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 78/100
What the filing says
Director ORBIMED ADVISORS LLC (WWB) bought 6.6M shares (~$20.0M) on the open market (48% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
Tradability signal
NO TRADE
No trade: the filing reads positive but the market is selling it (-6.7% since it hit EDGAR) — when our read and the tape disagree this hard, we stand aside. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $22.64 ▲ 0.00% | at our read · unknown $22.64 | +10 min · unknown $23.50 ▲ 3.80% | +30 min · unknown $23.00 ▲ 1.59% | +1 hr · unknown $23.09 ▲ 1.99% | +4 hrs · unknown $22.98 ▲ 1.50% |
The stock had already moved +0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.